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Brucellosis is a zoonotic infection that is usually transmitted from cattle to humans through ingestion of animal milk, direct contact 
with animal parts, or inhalation of aerosolized particles. In Korea, brucellosis seem to be transmitted through close contact with 
blood, fetus, urine, and placenta of domestic cow that has been infected by Brucella abortus, or inhalation of B. arbortus while 
examining or slaughtering cow. Brucella melitensis infection is rare in Korea and there have been no reported cases of B. meliten-
sis originating from other countries until now. This report details a case of complicated brucellosis with infective spondylitis in a 
48-year-old male construction worker recently returned from Iraq. Infection with B. melitensis was confirmed using 16s rRNA se-
quencing and omp31 gene analysis. The patient was successfully treated using a combination of rifampin, doxycycline, and strep-
tomycin, in accordance with WHO guidelines. This is the first reported case of complicated brucellosis with infective spondylitis 
in Korea caused by B. melitensis originating from Iraq.
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Case Report
Introduction
Brucellosis is a growing global health problem as a result of 
increased international travel that permits the spread of the 
infection from endemic areas to other parts of the world [1-3]. 
It is caused by Brucella, a small, slow growing, intracellular 
Gram-negative coccobacillus that is transmitted to humans by 
direct contact with infected animals or intake of contaminat-
ed raw animal products, such as unpasteurized milk [1, 4-7]. 
Brucellosis almost always causes fever, which may be associ-
ated with night sweats [5, 8]. Common treatment includes 
doxycycline and aminoglycosides, although complicated cas-
es, such as brucellosis combined with endocarditis, osteoar-
ticulitis, or neurobrucellosis, may require stronger medicati-
nos administered for a longer duration [9-11]. Brucellosis is 
endemic to the Mediterranean basin, the Persian gulf, India, 
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Mexico, and South America [1]. In Korea, the first human case 
was reported in 2002 [12]. Brucellosis in Korea is normally 
caused by Brucella abortus from cattle [5]. There have been 
no reported cases of brucellosis resulting from Brucella meli-
tensis in Korea until now [12]. This paper presents a case of 
spondylitis complicated by B. melitensis infection that result-
ed from ingesting contaminated sheep meat while in Iraq.
Case Report
A 48-year-old male Korean construction worker with no 
medical history developed fever and back pain while working 
in Karbala, Iraq. The patient went to a local hospital, where he 
received an intravenous steroid injection and oral antibiotics. 
After his fever spiked to 40℃ and his back pain worsened, the 
patient received 4 days of intravenous antibiotics. When the 
fever and back pain failed to improve, the patient returned to 
Korea for further evaluation. The patient was transported to a 
tertiary hospital in Seoul, Korea that was in the midst of an 
outbreak of Middle East Respiratory Syndrome (MERS). Due 
to the patient’s fever and recent travel to Iraq, he was isolated 
for 72 hours until a sputum test for MERS-CoV came back 
negative. On admission, the patient’s vitals were as follows: 
blood pressure 138/92 mmHg, pulse rate 84 beats per minute, 
respiratory rate 18 breaths per minute, and body temperature 
39℃. Laboratory tests showed a white blood cell count of 
9,900/mm3 with 60% neutrophils, hemoglobin level of 14.2 g/dL, 
platelet count of 176,000/mm3, erythrocyte sedimentation 
rate (ESR) of 24 mm/hr, and C-reactive protein level of 116.7 
mg/L (normal range, 0-8 mg/L).
The patient had recently undergone subgingival curettage, 
so a transthoracic echocardiography was performed to check 
for infective endocarditis. An MRI of the spine was also per-
formed to evaluate the patient’s back pain. No vegetation was 
seen during the echocardiography, but the MRI revealed pyo-
genic spondylitis involving L5 with phlegmon and showing 
posterior extension to the epidural space at the L5 and S1 lev-
els (Fig. 1). Meanwhile, the Brucella spp. was isolated on three 
separate blood cultures using MacConkey, and Brucella agars 
(Fig. 2). As such, we concluded that our patient had brucello-
sis causing infectious spondylitis [3]. We did not perform the 
bone biopsy or standard tube agglutination test.
We subsequently took a thorough history in order to deter-
mine the route of infection while waiting for lab results regard-
ing the brucellosis subspecies [2]. The patient reported attend-
ing barbeque parties that served sheep meat every 2-3 weeks 
during his 6-month stay in Iraq. The patient further reported 
consuming undercooked sheep meat and pasteurized milk on 
several occasions during these parties. Since brucellosis is usu-
ally transmitted from contaminated sheep and goat products, 
we concluded that this was the likely route of contamination 
[2]. The patient denied other contact with animals while in Iraq.
We initially began treatment with ceftriaxone (2 g/day) and 
vancomycin (45 mg/kg/day) until infective endocarditis was 
Figure 1. T2 added sagittal magnetic resonance image (contrast) of the 
lumbar spine taken on the third hospital day, showing pyogenic spondylitis 
involving L5 with phlegmon as well as posterior extension to the epidural 
space at the L5 and S1 levels (arrows). 
Figure 2. Gram stain of patient’s blood culture on the third hospital day. 
On Gram stain, the organisms appeared as faintly stained, Gram negative 
coccobacilli (×400).
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ruled out via echocardiograph. After blood cultures were posi-
tive for Brucella spp., we began rifampin (600 mg/day), doxy-
cycline (100 mg PO, q12h), and streptomycin (1 g/day) to tar-
get complicated brucellosis with infective spondylitis in 
accordance with WHO guidelines [3, 9, 10]. While on this 
treatment, that patient’s CRP levels dropped to 19 mg/dL on 
the 16th hospital day. After the patient’s fever resolved, CRP 
levels decreased to 13.1 mg/dL on the 26th hospital day. After 
5 months of treatment, CRP levels decreased to 1.0 mg/dL. We 
discontinued streptomycin on the 30th hospital day. Rifampin 
and doxycycline were discontinued on the 143th day since the 
initiation of treatment. 
Analysis using 16s rRNA sequencing was used to confirm the 
presence of Brucella spp.. We used a forward primer of 5’-TTG-
GAGAGTTTGATCCTGGCTC-3’ and a reverse primer of 
5’-GGCGTGGACTTCCAGGGTATCT-3’. Sequencing was com-
missioned by Macrogen. Blast and EzTaxon were used to ana-
lyze the sequence. According to Blast analysis, a 99.6% equiva-
lence (720 of 723 bp) was found with several subspecies of 
Brucella (B. abortus, Brucella suis, B. melitensis, Brucella ca-
nis, and Brucella pinnipedialis, among others). EzTaxon anal-
ysis demonstrated a 99.86% equivalence (722 of 723 bp) with 
several subspecies of Brucella (B. abortus, B. canis, Brucella 
ceti, B. melitensis, and Brucella microti, among others). The 
Brucella subspecies was confirmed as B. melitensis by se-
quencing the omp31 gene. By PCR assay targeting the BCSP31 
gene, Brucella spp. was confirmed. B. melitensis was con-
firmed by using PCR assay targeting the IS711 locus (Fig. 3).
Discussion
The incidence of brucellosis worldwide varies from less than 
0.03 to 160 per 100,000 persons. Brucellosis has been practi-
cally eradicated in developed countries and is now mostly 
found in Mediterranean and Middle Eastern countries, espe-
cially Iraq, Jordan, and Saudi Arabia, as well as areas of Latin 
America, particularly Mexico and Argentina, the Polynesian 
islands of Wallis and Futuna, and the Mexico/United States 
border. It has lately also been found in some Central Asian 
countries, such as Kyrgyzstan and Azerbaijan. The spread of 
the disease is attributed to increasing travel between affected 
countries [13]. The first case of brucellosis in Korea was re-
ported in 2002 [14]. The number of cases sharply increased 
between 2005-2008, with 158 cases in 2005, 215 cases in 2006, 
and 101 cases in 2007. As a result of improved treatment for 
affected persons and new vaccination programs for cows, the 
rate of cases declined, and there were only 7 cases of brucello-
sis diagnosed in 2016.
Until now, the major mode of transmission of brucellosis re-
mains unclear. However, brucellosis of Korea seem to be 
transmitted through close contact with blood, fetus, urine, and 
placenta of domestic cow that has been infected by B. abor-
tus, or inhalation of B. arbortus while examining or slaughter-
ing cow [15]. This case report details the first incidence of B. 
melitensis imported to Korea from a patient who recently vis-
ited Iraq that resulted in brucellosis and infective spondylitis. 
In this international era, brucellosis in Korea is no longer lim-
ited to B. abortus. In the future, more cases of imported bru-
cellosis are expected due to the fact that many Korean busi-
nesses are located in the Middle East, leading to increased 
exposure to pathogens endemic to this area.
Physicians should consider brucellosis in all patients pre-
senting with fever and a history of recent travel to brucello-
sis-endemic areas. 
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